We’re raising our price target on Eli Lilly as the obesity-drug boom rolls on

The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there’s more growth to be had.

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright, All Rights Reserved © UCWE Media